PNC Financial Services Group
BEAM icon

PNC Financial Services Group’s Beam Therapeutics BEAM Stock Holding History

PNC Financial Services Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.5K Sell
1,247
-236
-16% -$6.57K ﹤0.01% 3651
2026
Q2 		$50.9K Buy
1,483
+221
+18% +$6.67K ﹤0.01% 3335
2026
Q1 		$30.1K Buy
1,262
+153
+14% +$4.24K ﹤0.01% 3498
2025
Q4 		$30.7K Buy
1,109
+287
+35% +$7.32K ﹤0.01% 3447
2025
Q3 		$19.9K Buy
822
+64
+8% +$1.27K ﹤0.01% 3647
2025
Q2 		$12.9K Sell
758
-1,627
-68% -$28.3K ﹤0.01% 3764
2025
Q1 		$46.6K Buy
2,385
+268
+13% +$7.02K ﹤0.01% 3138
2024
Q4 		$52.5K Buy
2,117
+105
+5% +$2.68K ﹤0.01% 3077
2024
Q3 		$49.3K Buy
2,012
+42
+2% +$1.08K ﹤0.01% 3099
2024
Q2 		$46.2K Buy
1,970
+198
+11% +$4.86K ﹤0.01% 3072
2024
Q1 		$58.5K Buy
1,772
+208
+13% +$6.48K ﹤0.01% 2918
2023
Q4 		$42.6K Buy
1,564
+923
+144% +$22.9K ﹤0.01% 3052
2023
Q3 		$15.4K Buy
641
+297
+86% +$7.96K ﹤0.01% 3567
2023
Q2 		$11K Buy
344
+262
+320% +$8.5K ﹤0.01% 3837
2023
Q1 		$2.51K Buy
82
+33
+67% +$1.3K ﹤0.01% 4250
2022
Q4 		$1.92K Sell
49
-16
-25% -$717 ﹤0.01% 4273
2022
Q3 		$4K Buy
65
+43
+195% +$2.45K ﹤0.01% 4005
2022
Q2 		$0 Sell
22
-5,014
-100% -$199K ﹤0.01% 4486
2022
Q1 		$289K Sell
5,036
-7
-0.1% -$459 ﹤0.01% 2026
2021
Q4 		$402K Sell
5,043
-1,009
-17% -$86.4K ﹤0.01% 1842
2021
Q3 		$526K Buy
6,052
+240
+4% +$24.1K ﹤0.01% 1570
2021
Q2 		$748K Buy
5,812
+329
+6% +$26.2K ﹤0.01% 1362
2021
Q1 		$439K Buy
5,483
+131
+2% +$12.5K ﹤0.01% 1652
2020
Q4 		$436K Buy
5,352
+352
+7% +$17.3K ﹤0.01% 1566
2020
Q3 		$123K Buy
+5,000
New +$124K ﹤0.01% 2201

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Contrarius Group Holdings
Contrarius Group Holdings Hamilton, Bermuda $2.05B AUM 66.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

PNC Financial Services Group's BEAM Position: Q3 2026 in Review

PNC Financial Services Group reduced its Beam Therapeutics (BEAM) stake by 16% in Q3 2026, selling an estimated $6.57K and leaving 1,247 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3651.

PNC Financial Services Group first reported a position in BEAM in Q3 2020 and has held it in 25 quarters since. The position peaked at $748K in Q2 2021. 133 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • PNC Financial Services Group held 1,247 shares of Beam Therapeutics worth $30.5K as of Q3 2026.
  • PNC Financial Services Group sold 236 Beam Therapeutics shares in Q3 2026, an estimated $6.57K.
  • Beam Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3651 holding.
  • PNC Financial Services Group first reported a position in Beam Therapeutics in Q3 2020 and has held it in 25 quarters since.
  • PNC Financial Services Group's Beam Therapeutics position peaked at $748K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.